# Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine

> **NCT04600388** · — · COMPLETED · sponsor: **Theranica** · enrollment: 121 (actual)

## Conditions studied

- Menstrual Migraine

## Interventions

- **DEVICE:** Nerivio

## Key facts

- **NCT ID:** NCT04600388
- **Lead sponsor:** Theranica
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-09
- **Primary completion:** 2020-11-01
- **Final completion:** 2020-11-10
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04600388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04600388, "Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04600388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*